|
Name |
2-(Ethylthio)ethylamine
|
| Molecular Formula | C4H11NS | |
| IUPAC Name* |
2-ethylsulfanylethanamine
|
|
| SMILES |
CCSCCN
|
|
| InChI |
InChI=1S/C4H11NS/c1-2-6-4-3-5/h2-5H2,1H3
|
|
| InChIKey |
HJCTVUWPHAZTLI-UHFFFAOYSA-N
|
|
| Synonyms |
2-(Ethylthio)ethylamine; 36489-03-9; 2-(Ethylthio)ethanamine; 2-ethylsulfanylethanamine; 2-[Ethylthio]ethylamonium; 2-(ethylsulfanyl)ethanamine; Ethanamine, 2-(ethylthio)-; 2-(ethylsulfanyl)ethan-1-amine; 2-Aminoethylethyl sulfide; 2-ethylthioethylamine; 2-ethylthio-ethylamine; [2-(ethylthio)ethyl]amine; 2-(ethylsulfanyl)ethylamine; SCHEMBL152661; 2-(Ethylthio)ethylamine, 96%; DTXSID30189993; ALBB-011952; ZINC2146714; BBL104215; MFCD00014826; STL558079; AKOS000172300; MS-20057; DB-019507; FT-0611245; EN300-213208; F77934; F2147-1017
|
|
| CAS | 36489-03-9 | |
| PubChem CID | 148011 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 105.2 | ALogp: | 0.3 |
| HBD: | 1 | HBA: | 2 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 51.3 | Aromatic Rings: | 0 |
| Heavy Atoms: | 6 | QED Weighted: | 0.544 |
| Caco-2 Permeability: | -5.424 | MDCK Permeability: | 0.00000578 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.016 |
| Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.001 |
| 30% Bioavailability (F30%): | 0.001 |
| Blood-Brain-Barrier Penetration (BBB): | 0.76 | Plasma Protein Binding (PPB): | 12.48% |
| Volume Distribution (VD): | 1.158 | Fu: | 88.09% |
| CYP1A2-inhibitor: | 0.322 | CYP1A2-substrate: | 0.475 |
| CYP2C19-inhibitor: | 0.028 | CYP2C19-substrate: | 0.777 |
| CYP2C9-inhibitor: | 0.004 | CYP2C9-substrate: | 0.675 |
| CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.893 |
| CYP3A4-inhibitor: | 0.009 | CYP3A4-substrate: | 0.303 |
| Clearance (CL): | 8.084 | Half-life (T1/2): | 0.803 |
| hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.142 |
| Drug-inuced Liver Injury (DILI): | 0.135 | AMES Toxicity: | 0.139 |
| Rat Oral Acute Toxicity: | 0.82 | Maximum Recommended Daily Dose: | 0.04 |
| Skin Sensitization: | 0.276 | Carcinogencity: | 0.577 |
| Eye Corrosion: | 0.971 | Eye Irritation: | 0.534 |
| Respiratory Toxicity: | 0.904 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000539 | ![]() |
0.355 | D0V0LB | ![]() |
0.250 | ||
| ENC000355 | ![]() |
0.231 | D06CIE | ![]() |
0.200 | ||
| ENC000017 | ![]() |
0.208 | D03CHT | ![]() |
0.184 | ||
| ENC000524 | ![]() |
0.185 | D0FD0H | ![]() |
0.176 | ||
| ENC000817 | ![]() |
0.185 | D0OL6O | ![]() |
0.167 | ||
| ENC000139 | ![]() |
0.185 | D00WUF | ![]() |
0.158 | ||
| ENC001178 | ![]() |
0.184 | D09VAZ | ![]() |
0.158 | ||
| ENC000760 | ![]() |
0.182 | D05KEZ | ![]() |
0.158 | ||
| ENC000137 | ![]() |
0.182 | D00AMQ | ![]() |
0.158 | ||
| ENC000550 | ![]() |
0.182 | D01QLH | ![]() |
0.152 | ||